|
시장보고서
상품코드
1935301
음성 바이오마커 시장 : 치료 용도별, 최종사용자별, 지역별Vocal Biomarkers Market, By Therapeutic Application, By End User, By Geography |
||||||
음성 바이오마커 시장은 2026년에 37억 1,680만 달러로 추정되며, 2033년까지 101억 6,870만 달러에 달할 것으로 예측됩니다. 2026년부터 2033년까지 CAGR 15.5%로 성장할 것으로 전망됩니다.
| 보고서 내용 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 37억 1,680만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 예측 기간 2026-2033년 CAGR: | 15.50% | 2033년 예측치: | 101억 6,870만 달러 |
음성은 우울증, 파킨슨병, 관상동맥질환 등의 질환의 유무와 위험도를 파악하는 유용한 도구로 활용될 수 있습니다. 또한, 음성 및 발화 기술 관련 연구기관과 기업들은 정확한 질병 진단을 지원할 수 있는 음성 바이오마커를 발굴하기 위해 협력하고 있습니다. 음성 바이오마커 기술은 의료 진단 분야의 혁신이 될 수 있으며, 만성질환을 감지하기 위한 최소침습적 진단 절차를 가능하게 할 수 있습니다. 예를 들어, Beyond Verbal, Inc., Cogito Corporation, Sonde Health는 정신적, 신체적 건강 상태를 진단하기 위한 음성 기반 플랫폼을 개발 중입니다.
시장 역학
음성 바이오마커 기술은 심신 건강 진단 방법을 변화시키고, 헬스케어 산업 전체를 혁신할 수 있는 잠재력을 가지고 있습니다. 이 음성 기반 기술을 통해 조기 진단 및 예방적 치료가 가능합니다. 이를 통해 병원, 진료소, 그리고 개인이 건강 상태를 모니터링하고 적절한 의료 조치를 취할 수 있을 것으로 기대됩니다.
주요 기업들은 시장에서 확고한 입지를 구축하고 제품 포트폴리오를 강화하기 위해 제휴에 집중하고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2016년 6월 Sonde Health Inc.는 매사추세츠공과대학 링컨연구소로부터 다양한 정신적, 신체적 상태의 모니터링 및 진단을 위한 음성 기반 기술 플랫폼의 기술 라이선스를 취득했습니다. 또한, Beyond Verbal, Inc.는 2016년 메이요 클리닉(Mayo Clinic)과 파트너십을 맺고 정신적, 신체적 건강 진단에 도움이 되는 음성 바이오마커를 연구하고 식별하고 있습니다.
본 조사의 주요 특징
- 세계의 음성 바이오마커 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명할 것입니다.
- 시장 촉진요인, 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서에서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략 및 향후 계획을 기반으로 세계 음성 바이오마커 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내리는 데 도움이 될 것입니다.
- 이 세계 음성 바이오마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 음성 바이오마커 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 음성 바이오마커 시장 : 치료 용도별, 2026-2033년
제5장 세계의 음성 바이오마커 시장 : 최종사용자별, 2026-2033년
제6장 세계의 음성 바이오마커 시장 : 지역별, 2026-2033년
제7장 경쟁 구도
제8장 애널리스트의 추천사항
제9장 섹션
KSM 26.03.04Vocal Biomarkers Market is estimated to be valued at USD 3,716.8 Mn in 2026 and is expected to reach USD 10,168.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,716.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.50% | 2033 Value Projection: | USD 10,168.7 Mn |
Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson's disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.
Market Dynamics
The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.
Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter's voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.
Key features of the study
- This report provides in-depth analysis of the global vocal biomarkers market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global vocal biomarkers market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Corporation, and Cogito Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
- The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market
Market Segmentation
- Therapeutic Application Insights (Revenue, USD Mn, 2026 - 2033)
- Psychological Disorders
- Respiratory Disorders
- Cardiovascular Disorders
- End User Insights (Revenue, USD Mn, 2026 - 2033)
- Hospitals
- Health Insurers
- Academic & Research Institutions
- Government Organizations
- Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Beyond Verbal, Inc.
- Sonde Health Inc.
- Sharecare, Inc.
- IBM Corporation
- Cogito Corporation
- AudEERING
- VoiceSense
- Winterlight Labs
- Ellipsis Health
- Vocalis Health
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapeutic Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Vocal Biomarkers Market, By Therapeutic Application, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Psychological Disorders
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Respiratory Disorders
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardiovascular Disorders
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Vocal Biomarkers Market, By End User, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Health Insurers
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Academic & Research Institutions
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Government Organizations
- Market Share Analysis, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Vocal Biomarkers Market, By Region, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country/Region, 2026, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Beyond Verbal, Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sonde Health Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sharecare, Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- IBM Corporation
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Cogito Corporation
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- AudEERING
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- VoiceSense
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Winterlight Labs
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Ellipsis Health
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Vocalis Health
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Beyond Verbal, Inc.
8. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. Section
- References
- Research Methodology
- About Us and Sales Contact
